Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis.
Saved in:
| Title: | Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis. |
|---|---|
| Authors: | Toth DP; Probity Medical Research, Kitchener Ontario, Canada. drtoth@bellnet.ca, Papp K, Gratton D |
| Source: | Dermatologic therapy [Dermatol Ther] 2008 Nov-Dec; Vol. 21 Suppl 3, pp. S6-14. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print Cited Medium: Internet ISSN: 1529-8019 (Electronic) Linking ISSN: 13960296 NLM ISO Abbreviation: Dermatol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
